Daniel E. Blockmans
Leuven, VLG, Belgium
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 152 publications
Cough as a clinical manifestation of giant cell arteritis.
Journal: Scandinavian journal of rheumatology
Published: April 07, 2026
2025 EULAR recommendations for the management of polymyalgia rheumatica and primary large vessel vasculitis.
Journal: Annals of the rheumatic diseases
Published: March 31, 2026
Clinical outcomes of upadacitinib continuation vs withdrawal in giant cell arteritis through 2 years.
Journal: Annals of the rheumatic diseases
Published: March 14, 2026
Association between anti-synthetase syndrome and malignancy: a systematic review and meta-analysis.
Journal: Rheumatology (Oxford, England)
Published: November 30, 2025
Spectrum and significance of 18F-FDG-PET/CT abnormalities in VEXAS syndrome.
Journal: Rheumatology (Oxford, England)
Published: October 26, 2025
A phase 2, randomised, placebo-controlled study of guselkumab in adults with new-onset or relapsing giant cell arteritis.
Journal: Annals of the rheumatic diseases
Published: September 15, 2025
18F-Fluorodeoxyglucose Positron Emission Tomography Imaging Assessment Within a Randomized Controlled Trial in Giant Cell Arteritis.
Journal: Arthritis & rheumatology (Hoboken, N.J.)
Published: August 27, 2025
Reply to: Use of upadacitinib in giant cell arteritis.
Journal: Clinical and experimental rheumatology
Published: August 25, 2025
The TFIID complex is a new autoantibody target in systemic sclerosis.
Journal: Annals of the rheumatic diseases
Published: April 30, 2025
A Phase 3 Trial of Upadacitinib for Giant-Cell Arteritis.
Journal: The New England journal of medicine
Published: April 02, 2025
External validation of the polymyalgia rheumatica impact scale: a prospective cohort study.
Journal: Rheumatology advances in practice
Published: January 27, 2025
Last Updated: 09/26/2026